VIRTUAL Insights into Combination Therapies of Neoantigens and Checkpoint Inhibitors for More Successful Cancer Cures

Time: 1:00 pm
day: Day Two


  • Showing what strategies have been developed in combination with checkpoint inhibitors
  • Discriminating the value of the vaccine versus the checkpoint inhibitor
  • Uncovering the best pre-clinical designs to address issues associated with early stage and late stage cancer